COSTS OF TERMINAL CARE FOR PEOPLE WITH AIDS

被引:4
作者
BENNETT, CL
LUBECK, DP
MCSHANE, DJ
MATHEWS, JK
LIPIL, WH
机构
[1] URSUS MED GRP,REDWOOD CITY,CA
[2] STANFORD UNIV,MED CTR,SCH MED,DEPT MED,DIV IMMUNOL & RHEUMATOL,STANFORD,CA 94305
来源
AIDS PATIENT CARE | 1995年 / 9卷 / 01期
关键词
D O I
10.1089/apc.1995.9.7
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Despite the numerous studies on the costs of AIDS, little has been reported on the economic costs for terminal care. This study reports on the average monthly costs of care used in the last 6 months of life by a group of people with AIDS between 1984 and 1990. Hospital and outpatient visits, laboratory results, and medications were evaluated for all subjects. Standard costs (1990 dollars) were applied to all services. The 81 subjects received care in a large private medical practice located in northern California. The group was primarily male (98 percent), white (87 percent), and gay or bisexual (89 percent). Mean age at diagnosis of AIDS was 40.8 (SE = 1.1). Patients averaged a total of 2.9 (SE = 0.2) opportunistic infections (OIs) from the diagnosis of AIDS to death. Median survival was 13.2 months. The primary outcome measures were the components of the costs of terminal care: inpatient visits and outpatient costs. Covariates include location of death, year of death, and OIs. Average monthly terminal care resources included 8.3 days of in-hospital care, $8258 in costs for inpatient care, $840 in outpatient costs, and $9098 in total costs. Death at home increased in frequency (from 20 percent for 1984-1987 to 37 percent for 1987-1990). However, costs in the last 6 months of life did not change significantly as costs for patients who died in the hospital decreased and costs for patients who died at home increased over time. Policies that promote dying at home, while likely to affect patient quality of life, may not lower health care costs.
引用
收藏
页码:7 / 9
页数:3
相关论文
共 14 条
[1]  
BENNETT CL, 1992, J ACQ IMMUN DEF SYND, V4, P1
[2]  
*CTR DIS CONTR, 1991, HIV AIDS SURV REP
[3]   THE ECONOMIC-IMPACT OF THE 1ST 10,000 CASES OF ACQUIRED-IMMUNODEFICIENCY-SYNDROME IN THE UNITED-STATES [J].
HARDY, AM ;
RAUCH, K ;
ECHENBERG, D ;
MORGAN, WM ;
CURRAN, JW .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 255 (02) :209-211
[4]  
HAY JW, 1988, J ACQ IMMUN DEF SYND, V1, P466
[5]   THE LIFETIME COST OF TREATING A PERSON WITH HIV [J].
HELLINGER, FJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (04) :474-478
[6]  
HELLINGER FJ, 1990, PUBLIC HEALTH REP, V105, P1
[7]   MEDICAL-CARE COSTS OF PATIENTS WITH ACQUIRED IMMUNODEFICIENCY SYNDROME IN RICHMOND, VA - A QUANTITATIVE-ANALYSIS [J].
KAPLOWITZ, LG ;
TURSHEN, IJ ;
MYERS, PS ;
STALOCH, LA ;
BERRY, AJ ;
SETTLE, JT .
ARCHIVES OF INTERNAL MEDICINE, 1988, 148 (08) :1793-1797
[8]  
KIZER K, 1988, AIDS CALIFORNIA
[9]  
KIZER KW, 1987, UPDATED QUANTITATIVE
[10]  
MERZEL C, 1991, NOV AM PUB HLTH ASS, P10